JP2006501825A5 - - Google Patents

Download PDF

Info

Publication number
JP2006501825A5
JP2006501825A5 JP2004541707A JP2004541707A JP2006501825A5 JP 2006501825 A5 JP2006501825 A5 JP 2006501825A5 JP 2004541707 A JP2004541707 A JP 2004541707A JP 2004541707 A JP2004541707 A JP 2004541707A JP 2006501825 A5 JP2006501825 A5 JP 2006501825A5
Authority
JP
Japan
Prior art keywords
polypeptide
cervical cancer
nucleic acid
immunogenic composition
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004541707A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006501825A (ja
JP4755422B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/031726 external-priority patent/WO2004030636A2/en
Publication of JP2006501825A publication Critical patent/JP2006501825A/ja
Publication of JP2006501825A5 publication Critical patent/JP2006501825A5/ja
Application granted granted Critical
Publication of JP4755422B2 publication Critical patent/JP4755422B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004541707A 2002-10-03 2003-10-02 ヒトパピローマウイルス・ポリペプチドおよび免疫原性組成物 Expired - Lifetime JP4755422B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41592902P 2002-10-03 2002-10-03
US60/415,929 2002-10-03
PCT/US2003/031726 WO2004030636A2 (en) 2002-10-03 2003-10-02 Human papillomavirus polypeptides and immunogenic compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010181424A Division JP5398665B2 (ja) 2002-10-03 2010-08-13 ヒトパピローマウイルス・ポリペプチドおよび免疫原性組成物

Publications (3)

Publication Number Publication Date
JP2006501825A JP2006501825A (ja) 2006-01-19
JP2006501825A5 true JP2006501825A5 (enExample) 2006-11-16
JP4755422B2 JP4755422B2 (ja) 2011-08-24

Family

ID=32069921

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004541707A Expired - Lifetime JP4755422B2 (ja) 2002-10-03 2003-10-02 ヒトパピローマウイルス・ポリペプチドおよび免疫原性組成物
JP2010181424A Expired - Lifetime JP5398665B2 (ja) 2002-10-03 2010-08-13 ヒトパピローマウイルス・ポリペプチドおよび免疫原性組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010181424A Expired - Lifetime JP5398665B2 (ja) 2002-10-03 2010-08-13 ヒトパピローマウイルス・ポリペプチドおよび免疫原性組成物

Country Status (16)

Country Link
US (2) US7223408B2 (enExample)
EP (1) EP1553966B1 (enExample)
JP (2) JP4755422B2 (enExample)
KR (1) KR101145190B1 (enExample)
CN (1) CN1720060B (enExample)
AU (1) AU2003282731B2 (enExample)
BR (1) BR0314529A (enExample)
CA (1) CA2499837C (enExample)
CO (1) CO5700784A2 (enExample)
DK (1) DK1553966T3 (enExample)
ES (1) ES2391451T3 (enExample)
MX (1) MXPA05003395A (enExample)
NZ (1) NZ556544A (enExample)
PT (1) PT1553966E (enExample)
WO (1) WO2004030636A2 (enExample)
ZA (1) ZA200502618B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128922B2 (en) 1999-10-20 2012-03-06 Johns Hopkins University Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
WO2002012281A2 (en) 2000-08-03 2002-02-14 Johns Hopkins University Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
US7223408B2 (en) * 2002-10-03 2007-05-29 Wyeth Holdings Corporation Human papillomavirus polypeptides and immunogenic compositions
WO2004098526A2 (en) 2003-05-05 2004-11-18 Johns Hopkins University Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
GB0417430D0 (en) * 2004-08-05 2004-09-08 Uc3 A novel HPV vaccine comprising peptides from host cell proteins
US8399610B2 (en) * 2004-08-05 2013-03-19 University College Cardiff Consultants Limited HPV vaccine comprising peptides from host cell proteins
JP4474264B2 (ja) 2004-08-20 2010-06-02 生寶生物科技股▲ふん▼有限公司 子宮頸癌抑制の融合蛋白
JP5020825B2 (ja) 2004-12-08 2012-09-05 ジェン−プローブ・インコーポレーテッド 複数型のヒトパピローマウイルスに由来する核酸の検出
WO2006073970A2 (en) 2005-01-06 2006-07-13 The Johns Hopkins University Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
JP2008526248A (ja) 2005-01-14 2008-07-24 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン 生体試料におけるヒトパピローマウイルス検出のためのシステム、方法、および組成
CA2595726A1 (en) * 2005-01-26 2006-08-03 The Johns Hopkins University Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
EP2010572B1 (en) * 2006-04-19 2013-10-23 POSTECH Academy-Industry Foundation Fusion proteins comprising hpv polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer
US9085638B2 (en) 2007-03-07 2015-07-21 The Johns Hopkins University DNA vaccine enhancement with MHC class II activators
US8222214B2 (en) * 2007-06-01 2012-07-17 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Vaccine for the prevention of breast cancer relapse
US20090117123A1 (en) * 2007-11-02 2009-05-07 National Health Research Institutes Immunopeptides of hpv e6 and e7 proteins
US20120121715A1 (en) * 2008-01-02 2012-05-17 National Taiwan University DNA Vaccine Comprising IL-6-Encoding DNA Construct and Applications Thereof
EP2335730A1 (en) * 2009-12-18 2011-06-22 Deutsches Krebsforschungszentrum Fusion polypeptides and their use for prevention and treatment of cancer
KR101197627B1 (ko) * 2010-01-18 2012-11-07 (주)레퍼런스바이오랩 Ｈｐｖ 감염과 관련된 암의 치료용 조성물
EP2536853B1 (en) * 2010-02-16 2018-02-14 Becton Dickinson and Company Assay for detecting closely- related serotypes of human papillomavirus (hpv)
JP6153866B2 (ja) 2010-05-25 2017-06-28 キアゲン ガイサーズバーグ アイエヌシー． 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ
WO2012020871A1 (ko) * 2010-08-13 2012-02-16 주식회사 제넥신 사람 파필로마바이러스 변형체 및 면역 증강제를 포함하는 자궁경부암 예방 또는 치료용 조성물
EA033242B1 (ru) * 2011-10-12 2019-09-30 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Усовершенствованные нуклеиновые кислоты и белки вируса человеческой папилломы, вакцины и композиции на их основе и способы индукции иммунного ответа против впч с их применением
AU2012356969B2 (en) * 2011-12-21 2017-05-04 Nykode Therapeutics ASA Vaccines against HPV
WO2013112549A1 (en) 2012-01-24 2013-08-01 Sanford Research/USD Polynucleotides for treating oncogenic viral polypeptide positive tumors
CN103288931B (zh) * 2012-02-24 2015-05-27 宋硕 人类乳头瘤病毒免疫原性多肽、其制备方法及应用
EA034056B1 (ru) * 2013-03-12 2019-12-23 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Усовершенствованные вакцины против вируса папилломы человека и способы их применения
MX369709B (es) * 2013-03-15 2019-11-19 Univ Pennsylvania Vacunación mejorada contra tirosinasa.
WO2016024255A1 (en) * 2014-08-15 2016-02-18 Genexine, Inc. Methods of treating cervical cancer
JP5973007B2 (ja) * 2015-01-30 2016-08-17 ジェネクサイン・インコーポレーテッド ヒトパピローマウイルス変形体及び免疫増強剤を含む子宮頸癌の予防または治療用組成物
PT3283508T (pt) * 2015-04-17 2021-06-21 Alpine Immune Sciences Inc Proteínas imuno modulatórias com afinidades afináveis
HK1246183A1 (zh) * 2015-06-10 2018-09-07 Hookipa Biotech Gmbh Hpv疫苗
ES2809508T3 (es) * 2015-10-06 2021-03-04 Invectys Estructuras artificiales de poliepítopos para uso en inmunoterapia
AU2017205270B2 (en) 2016-01-08 2024-01-18 Nykode Therapeutics ASA Therapeutic anticancer neoepitope vaccine
AU2017250358B2 (en) 2016-04-15 2023-06-01 Alpine Immune Sciences, Inc. ICOS ligand variant immunomodulatory proteins and uses thereof
BE1024774B1 (fr) 2016-09-29 2018-07-02 Glaxosmithkline Biologicals Sa Compositions et procedes de traitement
CN112574317B (zh) * 2017-01-24 2023-12-05 南京益康生物医药有限公司 一种重组蛋白及药物组合物与应用
JP2020516601A (ja) * 2017-04-07 2020-06-11 ホオキパ バイオテック ジーエムビーエイチ 固形腫瘍を治療するためのアレナウイルス粒子
EP3461497A1 (en) 2017-09-27 2019-04-03 GlaxoSmithKline Biologicals S.A. Viral antigens
US20220334132A1 (en) * 2019-08-08 2022-10-20 The Trustees Of Indiana University Methods for identifying and treating urinary tract infections
KR20220109444A (ko) 2020-04-24 2022-08-04 주식회사 제넥신 자궁경부암 치료방법
CN114478712B (zh) * 2022-03-29 2022-09-23 深圳吉诺因生物科技有限公司 Hpv抗原表位及其鉴定方法、应用
WO2024145863A1 (en) * 2023-01-05 2024-07-11 Virogin Biotech (Shanghai) Ltd. A NOVEL mRNA VACCINE FOR THE TREATMENT AND PREVENTION OF HPV-ASSOCIATED LESIONS AND TUMORS
CN117925916A (zh) * 2024-03-11 2024-04-26 广州市金域转化医学研究院有限公司 Hpv dna的e6基因在制备浸润性宫颈癌诊断产品中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105383D0 (en) 1991-03-14 1991-05-01 Immunology Ltd An immunotherapeutic for cervical cancer
AUPN015794A0 (en) * 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
AUPN443995A0 (en) * 1995-07-27 1995-08-17 Csl Limited Papillomavirus polyprotein
GB9717953D0 (en) * 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine
CN1433428A (zh) * 2000-04-05 2003-07-30 冲击诊断公司 辨别人乳头瘤病毒的免疫学方法
US7223408B2 (en) * 2002-10-03 2007-05-29 Wyeth Holdings Corporation Human papillomavirus polypeptides and immunogenic compositions

Similar Documents

Publication Publication Date Title
JP2006501825A5 (enExample)
JP2006187292A5 (enExample)
JP2017513502A5 (enExample)
JP2001081042A5 (enExample)
JP2014527404A5 (enExample)
JP2004504057A5 (enExample)
JP2002510494A5 (enExample)
JP2004532023A5 (enExample)
JP2008529558A5 (enExample)
UA92782C2 (ru) Новый поверхностный белок haemophilus influenzae (белок е; ре)
JPH09322781A5 (enExample)
JP2004511201A5 (enExample)
JP2005505286A5 (enExample)
JP2002542827A5 (enExample)
JP2002503683A5 (enExample)
CA2505942A1 (en) West nile virus vaccine
JP2003511010A (ja) ヒト細胞中での発現用に最適化された合成ヒトパピローマウイルス遺伝子
JP2004537308A5 (enExample)
RU2363492C2 (ru) Вакцина
WO2004085633A8 (en) A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
KR20200027956A (ko) 키메라 바이러스-유사 입자 및 면역 반응의 항원-특이적 재지향자로서의 이의 용도
JP2004501650A5 (enExample)
JP2012516140A5 (enExample)
JP2002512800A5 (enExample)
JP2002539781A5 (enExample)